Prognostic significance of Ror2 and Wnt5a expression in medulloblastoma

Brain Pathology

Volumn 23, Issue 4, 2013, Pages 445-453

  Lee, Seung Eun ^a   Lim, So Dug ^b   Kang, So Young ^a   Suh, Sang Bum ^a   Suh, Yeon Lim ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Konkuk University Hospital   (South Korea)

Author keywords

medulloblastoma; prognostic factor; Ror2; Wnt 5a; WNT pathway

Indexed keywords

BETA CATENIN; MESSENGER RNA; ROR2 PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; WNT5A PROTEIN;

ADOLESCENT; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; OVERALL SURVIVAL; PRESCHOOL CHILD; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; BETA CATENIN; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MEDULLOBLASTOMA; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTORS; RETROSPECTIVE STUDIES; SIGNAL TRANSDUCTION; TISSUE ARRAY ANALYSIS; WNT PROTEINS; YOUNG ADULT;

EID: 84879205263     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12017     Document Type: Article

References (31)

1. Deloukas P, Schuler GD, Gyapay G, Beasley EM, Soderlund C, Rodriguez-Tome P, et al (1998) A physical map of 30,000 human genes. Science 282: 744-746.
2. Edris B, Espinosa I, Muhlenberg T, Mikels A, Lee CH, Steigen SE, et al (2012) ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour. J Pathol 227: 223-233.
3. Ellison DW, (2010) Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease. Acta Neuropathol 120: 305-316.
4. Fattet S, Haberler C, Legoix P, Varlet P, Lellouch-Tubiana A, Lair S, et al (2009) Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics. J Pathol 218: 86-94.
5. Forrester WC, (2002) The Ror receptor tyrosine kinase family. Cell Mol Life Sci 59: 83-96.
6. Geng M, Cao YC, Chen YJ, Jiang H, Bi LQ, Liu XH, (2012) Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis. World J Gastroenterol 18: 1328-1338.
7. Giangaspero F, Rigobello L, Badiali M, Loda M, Andreini L, Basso G, et al (1992) Large-cell medulloblastomas. A distinct variant with highly aggressive behavior. Am J Surg Pathol 16: 687-693.
8. Giles RH, van Es JH, Clevers H, (2003) Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653: 1-24.
9. Katoh M, (2005) WNT/PCP signaling pathway and human cancer (review). Oncol Rep 14: 1583-1588.
10. Kobayashi M, Shibuya Y, Takeuchi J, Murata M, Suzuki H, Yokoo S, et al (2009) Ror2 expression in squamous cell carcinoma and epithelial dysplasia of the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107: 398-406.
11. Kongkham PN, Northcott PA, Croul SE, Smith CA, Taylor MD, Rutka JT, (2010) The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma. Oncogene 29: 3017-3024.
12. Kool M, Korshunov A, Remke M, Jones DT, Schlanstein M, Northcott PA, et al (2012) Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol 123: 473-484.
13. Lara E, Calvanese V, Huidobro C, Fernandez AF, Moncada-Pazos A, Obaya AJ, et al (2010) Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer. Mol Cancer 9: 170.
14. Li C, Chen H, Hu L, Xing Y, Sasaki T, Villosis MF, et al (2008) Ror2 modulates the canonical Wnt signaling in lung epithelial cells through cooperation with Fzd2. BMC Mol Biol 9: 11.
15. Liu C, Tu Y, Sun X, Jiang J, Jin X, Bo X, et al (2011) Wnt/beta-catenin pathway in human glioma: expression pattern and clinical/prognostic correlations. Clin Exp Med 11: 105-112.
16. Logan CY, Nusse R, (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810.
17. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109.
18. Masiakowski P, Carroll RD, (1992) A novel family of cell surface receptors with tyrosine kinase-like domain. J Biol Chem 267: 26181-26190.
19. McDonald SL, Silver A, (2009) The opposing roles of Wnt-5a in cancer. Br J Cancer 101: 209-214.
20. Mikels AJ, Nusse R, (2006) Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. Plos Biol 4: e115.
21. Nakagawara A, (2001) Trk receptor tyrosine kinases: a bridge between cancer and neural development. Cancer Lett 169: 107-114.
22. O'Connell MP, Fiori JL, Xu M, Carter AD, Frank BP, Camilli TC, et al (2010) The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma. Oncogene 29: 34-44.
23. Oishi I, Sugiyama S, Liu ZJ, Yamamura H, Nishida Y, Minami Y, (1997) A novel drosophila receptor tyrosine kinase expressed specifically in the nervous system. Unique structural features and implication in developmental signaling. J Biol Chem 272: 11916-11923.
24. Oishi I, Suzuki H, Onishi N, Takada R, Kani S, Ohkawara B, et al (2003) The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway. Genes Cells 8: 645-654.
25. Oldridge M, Fortuna AM, Maringa M, Propping P, Mansour S, Pollitt C, et al (2000) Dominant mutations in ROR2, encoding an orphan receptor tyrosine kinase, cause brachydactyly type B. Nat Genet 24: 275-278.
26. Pinto D, Clevers H, (2005) Wnt control of stem cells and differentiation in the intestinal epithelium. Exp Cell Res 306: 357-363.
27. Saldanha J, Singh J, Mahadevan D, (1998) Identification of a frizzled-like cysteine rich domain in the extracellular region of developmental receptor tyrosine kinases. Protein Sci 7: 1632-1635.
28. Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, Yang Y, (2003) Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol 162: 899-908.
29. Torres MA, Yang-Snyder JA, Purcell SM, DeMarais AA, McGrew LL, Moon RT, (1996) Activities of the Wnt-1 class of secreted signaling factors are antagonized by the Wnt-5A class and by a dominant negative cadherin in early Xenopus development. J Cell Biol 133: 1123-1137.
30. Wright TM, Brannon AR, Gordan JD, Mikels AJ, Mitchell C, Chen S, et al (2009) Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma. Oncogene 28: 2513-2523.
31. Yamanaka H, Moriguchi T, Masuyama N, Kusakabe M, Hanafusa H, Takada R, et al (2002) JNK functions in the non-canonical Wnt pathway to regulate convergent extension movements in vertebrates. EMBO Rep 3: 69-75.